Intrahepatic Cholestasis of Pregnancy and Fetomaternal Outcomes: A Retrospective Study from Uttarakhand, India
Purnima Upreti
Keywords :
Bile acid levels, Intrahepatic cholestasis of pregnancy, Meconium-stained liquor, Pregnancy outcomes, Serum ursodeoxycholic acid
Citation Information :
Upreti P. Intrahepatic Cholestasis of Pregnancy and Fetomaternal Outcomes: A Retrospective Study from Uttarakhand, India. J South Asian Feder Obs Gynae 2024; 16 (5):479-485.
Background: Intrahepatic cholestasis of pregnancy (ICP) is a late pregnancy disorder marked by generalized itching, elevated liver enzymes, and spontaneous resolution after delivery. Its origins are multifaceted, and its impact on fetomaternal health is noteworthy. However, research on ICP remains limited, especially in Uttarakhand.
Aim: This study endeavors to investigate the occurrence, connections, and pregnancy results associated with ICP.
Methods: Between July 2020 and June 2022, this retrospective descriptive study was conducted at a tertiary healthcare center in Uttarakhand, India. The study included pregnant women diagnosed with ICP, who met the specified inclusion criteria. Maternal and neonatal data were extracted from medical records and analyzed using SPSS version 23.
Results: The study revealed an ICP incidence of 4.3%. Participants aged 26–30 years accounted for 49.5% of the sample, with 50.5% being primigravida. Generalized itching without rashes emerged as the most common symptom. Pre-eclampsia affected 10.9% of participants, and gestational diabetes affected 9.8%.
The average period of gestation at delivery was 37 ± 1.2 weeks, with 36.9% of cases requiring induced labor. Cesarean section was performed in 33% of cases, and 22.3% exhibited meconium-stained liquor. Intrapartum fetal distress was observed in 13% of cases. Adverse neonatal outcomes included preterm birth (25.2%), low APGAR scores (7.2%), neonatal intensive care unit (NICU) admission (20.9%), and stillbirths (1.6%). Maternal serum bile acid levels showed a significant association with poor neonatal outcomes.
Conclusion: Intrahepatic cholestasis of pregnancy carries increased risks of gestational diabetes mellitus and pre-eclampsia, along with higher rates of induction of labor and cesarean sections. Furthermore, it leads to adverse neonatal outcomes, strongly linked to levels of bile acids in the mother's serum.
Clinical significance: The study highlights the significant association between levels of bile acids in the mother's serum and adverse neonatal outcomes. Monitoring maternal serum bile acid levels could predict poor neonatal outcomes and aid in the management of ICP-complicated pregnancies.
Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Research in Hepatol and Gastroenterol 2016;40(2):141–153. DOI: 10.1016/j.clinre.2015.12.008.
Marathe JA, Lim WH, Metz MP, et al. A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. Eur J Obstet Gynecol Reproduct Biol 2017;218:33–38. DOI: 10.1016/j.ejogrb.2017.09.012.
Rook M, Vargas J, Caughey A, et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. Plos One 2012;7(3):e28343. DOI: 10.1371/journal.pone.0028343.
Abedin P, B. Weaver J, Egginton E. Intrahepatic cholestasis of pregnancy: Prevalence and ethnic distribution. Ethn Health 1999;4 (1–2):35–37. DOI: 10.1080/13557859998173.
Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014;124:120–133. DOI: 10.1097/AOG.00000000000 00346.
Bacq Y, le Besco M, Lecuyer AI, et al. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment. Dig Liver Dis 2017;49(1):63–69. DOI: 10.1016/j.dld.2016.10.006.
Martineau M, Raker C, Powrie R, et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reproduct Biol 2014;176:80–85. DOI: 10.1016/j.ejogrb.2013.12.037.
Wikström Shemer E, Marschall HU, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: A 12-year population-based cohort study. BJOG 2013;120(6):717–723. DOI: 10.1111/1471-0528.12174.
Estiu MC, Frailuna MA, Otero C, et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One. 2017;12(4):e0176504. DOI: 10.1371/journal.pone.0176504.
Zeca E, De Luca D, Marras M, et al. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics 2006;117(5):1669–1672. DOI: 10.1542/peds.2005-1801.
American College of Obstetricians and Gynecologists. ACOG committee opinion no. 560: Medically indicated late-preterm and early-term deliveries. Obstet Gynecol 2013;121(4):908–910. DOI: 10.1097/01.AOG.0000428648.75548.00.
Das S, Roy A. A study on intrahepatic cholestasis in pregnancy to evaluate risk factors for adverse perinatal outcome: An experience from a tertiary care center of East India. J Med Sci Health 2020;6(3): 16–23. DOI: 10.46347/jmsh.2020.v06i03.002.
Luo M, Tang M, Jiang F, et al. Intrahepatic cholestasis of pregnancy and associated adverse maternal and fetal outcomes: A retrospective case-control study. Gastroenterol Res Pract 2021;25:2021.6641023. DOI: 10.1155/2021/6641023.
Pegu B, Mehrotra M, Yadav A, et al. Cholestasis of pregnancy: A prospective analysis from a South Andaman teaching hospital. Int J Reprod Contracept Obstet Gynecol 2019;8(5):1895–1899. DOI: 10.18203/2320-1770.ijrcog20191939.
Ghimire SP, Ghimire A, Jha GS, et al. Feto-maternal outcomes in intrahepatic cholestasis in pregnancy in a tertiary care centre in Eastern Nepal. J Nobel Med Coll 2016;5(1):20–25. DOI: 10.3126/jonmc.v5i1.15749.
Aftab N, Faraz S, Hazari K, et al. Maternal and fetal outcome in intrahepatic cholestasis of pregnancy in a multicultural society conducted at a tertiary care hospital in Dubai. Dubai Med J 2021;4(1):53–59. DOI: 10.1159/000513717.
Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: A prospective population-based case-control study. Hepatology 2014;59(4):1482–1491. DOI: 10.1002/hep.26617.
Arthuis C, Diguisto C, Lorphelin H, et al. Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study. PloS One 2020;15(2):e0228213. DOI: 10.1371/journal.pone.0228213.
Feng C, Li WJ, He RH, et al. Impacts of different methods of conception on the perinatal outcome of intrahepatic cholestasis of pregnancy in twin pregnancies. Sci Rep 2018;8(1):1–8. DOI: 10.1038/s41598-018-22387-6.
Mahajan N, Afzal A, Lone MI. Outcome of pregnancy complicated by obstetric cholestasis: A prospective study. Int J Sci Study 2017;5(3):268–271. DOI: 10.17354/ijss/2017/311.
Çelik S, Çalışkan CS, Çelik H, et al. Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy. Ginekol Pol 2019;90(4):217–222. DOI: 10.5603/GP.2019.0039.
Kant A, Goswami S, Gupta U, et al. Maternal and perinatal outcome in cholestasis of pregnancy: A study in tertiary care hospital in North India. Int J Reprod Contracept Obstet Gynecol 2018;7(12): 5066–5071. DOI: 10.18203/2320-1770.ijrcog20184968.
Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses. Lancet 2019;393(10174):899–909. DOI: 10.1016/S0140-6736(18)31877-4.
Mor M, Shmueli A, Krispin E, et al. Intrahepatic cholestasis of pregnancy as a risk factor for preeclampsia. Arch Gynecol Obstet 2020 Mar;301(3):655–664. DOI: 10.1007/s00404-020-05456-y.
Sepulveda WH, Gonzalez C, Cruz MA, et al. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reproduct Biol 1991;42(3):211–215. DOI: 10.1016/0028-2243(91)90222-7.
Kumar DP, Rajagopal S, Mahavadi S, et al. Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem Biophys Res Comm 2012;427(3):600–605. DOI: 10.1016/j.bbrc.2012.09.104.
Ma K, Saha PK, Chan L, et al. Farnesoid X receptor is essential for normal glucose homeostasis. The Journal of Clinical Investigation. 2006;116(4):1102–1109. DOI: 10.1172/JCI25604.
Kenyon AP, Piercy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: A series of 70 cases. BJOG 2002;109(3):282–288. DOI: 10.1111/j.1471-0528.2002.01368.x.
Brouwers L, Koster MP, Page-Christiaens GC, et al. Intrahepatic cholestasis of pregnancy: Maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015;212(1):100.e1–e7. DOI: 10.1016/j.ajog.2014.07.026.
Nichols AA. Cholestasis of pregnancy: A review of the evidence. J Perinat Neonatal Nurs 2005;19:217–225. DOI: 10.1097/00005237-200507000-00007.
Heikkinen J, Mäentausta O, Ylöstalo P, et al. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. BJOG 1981;88(3):240–245. PMID: 7470414.
Boregowda G, Shehata HA. Gastrointestinal and liver disease in pregnancy. Best Pract Res Clin Obstet Gynaecol 2013;27(6):835–853. DOI: 10.1016/j.bpobgyn.2013.07.006.
Cui D, Zhong Y, Zhang L, et al. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. J Obstet Gynaecol Res 2017;43(9):1411–1420. DOI: 10.1111/jog.13399.
Glantz A, Marschall HU, Mattsson LÅ. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004;40(2):467–474. DOI: 10.1002/hep.20336.
Germain AM, Kato S, Carvajal JA, et al. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003;189(2):577–582. DOI: 10.1067/s0002-9378(03) 00545-3.
Kaneko TA, Sato TO, Katsuya HI, et al. Surfactant therapy for pulmonary edema due to intratracheally injected bile acid. Criti Care Med 1990;18(1):77–83. DOI: 10.1097/00003246-199001000-00017.
Li L, Cong L, Chen Y, et al. Risk factors for adverse fetal outcomes in patients with intrahepatic cholestasis of pregnancy. Biomed Res 2017;28:9193–9197.
Kawakita T, Parikh LI, Ramsey PS, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2015;213(4):570.e1–e8. DOI: 10.1016/j.ajog.2015.06.021.
Reid R, Ivey KJ, Rencoret RH, et al. Fetal complications of obstetric cholestasis. Br med J 1976;1(6014):870–872. DOI: 10.1136/bmj.1.6014.870.
Al Inizi S, Gupta R, Gale A. Fetal tachyarrhythmia with atrial flutter in obstetric cholestasis. Int J Gynaecol Obstet 2006;93(1):53–54. DOI: 10.1016/j.ijgo.2005.12.030.